Article Details
Retrieved on: 2022-12-19 16:40:22
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
One analyst called the readout a “major win” for the biotech company and for development of fatty liver disease drugs. Published Dec. 19, 2022.
Article found on: www.biopharmadive.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here